Jan van Laar
Impact in
- Hematology top 2%
- Autoimmune and Inflammatory Disorders Research
- Infectious Diseases top 5%
- Parvovirus B19 Infection Studies
Papers in
-
- Gastric Cancer Management and Outcomes 5
- Oncology 17
- Colorectal Cancer Treatments and Studies 13
- Cancer Treatment and Pharmacology 6
- Co-authors
- Godefridus J. Peters (13 shared papers)C.L. van der Wilt (11 shared papers)Michael Girschikofsky (2 shared papers)Paul La Rosée (2 shared papers)Michael B. Jordan (2 shared papers)Rafał Machowicz (2 shared papers)Gritta Janka (2 shared papers)Gunnar Lachmann (2 shared papers)
- Journals
- European Journal of Cancer (4 papers)Blood (3 papers)Clinical and Experimental Rheumatology (2 papers)Clinical Immunology (2 papers)Journal of Translational Medicine (2 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Jan van Laar
55 papers receiving 1.6k citations
Jan van Laar's Hit Papers
Peers
Comparison fields: 5 of 92
- Hematology 599
- Infectious Diseases 454
- Immunology 485
- Rheumatology 234
- Ophthalmology 122
Countries citing papers authored by Jan van Laar
This map shows the geographic impact of Jan van Laar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan van Laar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan van Laar more than expected).
Fields of papers citing papers by Jan van Laar
This network shows the impact of papers produced by Jan van Laar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan van Laar. The network helps show where Jan van Laar may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan van Laar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recommendations for the management of hemophagocytic lymphohistiocytosis in adults Hit paper breakdown → | 2019 | 598 |
| 2 | Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines. | 1999 | 125 |
| 3 | 2016 | 107 | |
| 4 | 2022 | 100 | |
| 5 | 1998 | 89 | |
| 6 | 2012 | 66 | |
| 7 | 2021 | 57 | |
| 8 | 2014 | 47 | |
| 9 | 2017 | 36 | |
| 10 | 2014 | 32 | |
| 11 | 2014 | 32 | |
| 12 | 1992 | 30 | |
| 13 | Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model. | 1996 | 28 |
| 14 | 1992 | 27 | |
| 15 | 1996 | 24 | |
| 16 | 2020 | 21 | |
| 17 | 2002 | 20 | |
| 18 | 1992 | 20 | |
| 19 | 1995 | 19 | |
| 20 | 2022 | 14 |
About Jan van Laar
Jan van Laar is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Rheumatology, Ophthalmology and Physiology, having authored 57 papers that have together received 1.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (13 papers), Ocular Diseases and Behçet’s Syndrome (12 papers), Autoimmune and Inflammatory Disorders Research (7 papers), Sarcoidosis and Beryllium Toxicity Research (7 papers), Retinal and Optic Conditions (7 papers), Cancer Treatment and Pharmacology (6 papers), IgG4-Related and Inflammatory Diseases (6 papers) and Gastric Cancer Management and Outcomes (5 papers). The work is most often cited by research in Hematology (599 citations), Infectious Diseases (454 citations), Immunology (485 citations), Rheumatology (234 citations) and Ophthalmology (122 citations). Jan van Laar has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Godefridus J. Peters, C.L. van der Wilt, Michael Girschikofsky, Paul La Rosée, Michael B. Jordan, Rafał Machowicz, Gritta Janka, Gunnar Lachmann, Jan‐Inge Henter and Melissa Hines. Their work appears in journals such as European Journal of Cancer, Blood, Clinical and Experimental Rheumatology, Clinical Immunology and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.